127 related articles for article (PubMed ID: 17523278)
1. p53 genetic abnormalities and P-glycoprotein expression in stump and primary gastric carcinomas.
Oliver I; Lacueva J; Barberá V; Caldés T; Teruel A; Costa D; Medrano J; Pérez-Vázquez T; Quesada P; Ferragut J; Calpena R
Hepatogastroenterology; 2007 Mar; 54(74):377-81. PubMed ID: 17523278
[TBL] [Abstract][Full Text] [Related]
2. K-ras mutations in gastric stump carcinomas and in carcinomas from the non-operated stomach.
van Rees BP; Musler A; Caspers E; Drillenburg P; Craanen ME; Polkowski W; Chibowski D; Offerhaus GJ
Hepatogastroenterology; 1999; 46(27):2063-8. PubMed ID: 10430398
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
[TBL] [Abstract][Full Text] [Related]
4. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
5. Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression.
Hanazono K; Natsugoe S; Stein HJ; Aikou T; Hoefler H; Siewert JR
Oncol Rep; 2006 Apr; 15(4):821-4. PubMed ID: 16525665
[TBL] [Abstract][Full Text] [Related]
6. TP53 and gastric carcinoma: a review.
Fenoglio-Preiser CM; Wang J; Stemmermann GN; Noffsinger A
Hum Mutat; 2003 Mar; 21(3):258-70. PubMed ID: 12619111
[TBL] [Abstract][Full Text] [Related]
7. Patterns of p53 gene mutations in head and neck cancer: full-length gene sequencing and results of primary radiotherapy.
Saunders ME; MacKenzie R; Shipman R; Fransen E; Gilbert R; Jordan RC
Clin Cancer Res; 1999 Sep; 5(9):2455-63. PubMed ID: 10499619
[TBL] [Abstract][Full Text] [Related]
8. Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach.
Safatle-Ribeiro AV; Ribeiro Júnior U; Reynolds JC; Gama-Rodrigues JJ; Iriya K; Kim R; Bakker A; Swalsky PA; Pinotti HW; Finkelstein SD
Cancer; 1996 Dec; 78(11):2288-99. PubMed ID: 8940997
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evidence of p53 overexpression in gastric epithelial dysplasia.
Rugge M; Shiao YH; Correa P; Baffa R; DiMario F
Cancer Epidemiol Biomarkers Prev; 1992; 1(7):551-4. PubMed ID: 1302567
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Shimada S; Tashima S; Yamaguchi K; Matsuzaki H; Ogawa M
J Exp Clin Cancer Res; 1999 Mar; 18(1):111-8. PubMed ID: 10374690
[TBL] [Abstract][Full Text] [Related]
11. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor structural alterations in gastric cancer.
Moutinho C; Mateus AR; Milanezi F; Carneiro F; Seruca R; Suriano G
BMC Cancer; 2008 Jan; 8():10. PubMed ID: 18199332
[TBL] [Abstract][Full Text] [Related]
13. Multiple early gastric stump carcinomas after gastrectomy for peptic ulcer.
Yamashita Y; Chung YS; Maeda K; Sawada T; Yoshikawa K; Maekawa Z; Yamamoto T; Sowa M
Am J Gastroenterol; 1998 Sep; 93(9):1575-8. PubMed ID: 9732951
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.
Salinas-Sánchez AS; Atienzar-Tobarra M; Lorenzo-Romero JG; Sánchez-Sánchez F; Giménez-Bachs JM; Donate-Moreno MJ; Pastor-Navarro H; Hernández-Millán I; Segura-Martín M; Escribano-Martínez J
Urol Int; 2007; 79(4):321-7. PubMed ID: 18025850
[TBL] [Abstract][Full Text] [Related]
15. Changes in P-glycoprotein expression in gastric carcinoma with respect to distant gastric mucosa may be influenced by p53.
Lacueva FJ; Calpena R; Medrano J; Teruel A; Mayol MJ; Graells ML; Camarasa MV; Perez-Vazquez MT; Ferragut JA
Cancer; 2000 Jul; 89(1):21-8. PubMed ID: 10896996
[TBL] [Abstract][Full Text] [Related]
16. The RR genotype of codon 72 of p53 gene reduces the development of intestinal metaplasia.
Szoke D; Molnár B; Solymosi N; Sipos F; Galamb O; Gyorffy A; Tulassay Z
Dig Liver Dis; 2009 Mar; 41(3):179-84. PubMed ID: 18567547
[TBL] [Abstract][Full Text] [Related]
17. p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer.
George B; Datar RH; Wu L; Cai J; Patten N; Beil SJ; Groshen S; Stein J; Skinner D; Jones PA; Cote RJ
J Clin Oncol; 2007 Dec; 25(34):5352-8. PubMed ID: 18048815
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of p53 exon 4 mutations in soft tissue sarcoma.
Das P; Kotilingam D; Korchin B; Liu J; Yu D; Lazar AJ; Pollock RE; Lev D
Cancer; 2007 Jun; 109(11):2323-33. PubMed ID: 17429838
[TBL] [Abstract][Full Text] [Related]
19. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.
Lindgren D; Liedberg F; Andersson A; Chebil G; Gudjonsson S; Borg A; Månsson W; Fioretos T; Höglund M
Oncogene; 2006 Apr; 25(18):2685-96. PubMed ID: 16532037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
